Mark Fowler is a Safety Scientist (Cell Biologist) at Unilever, where they investigate animal-free alternatives to serum-containing mediums and lung microfluidic in vitro models. With a background that includes a PhD in Cellular Microbiology from the University of Southampton and extensive experience in cell biology, Mark has contributed to research in diabetes, cardiovascular health, and ageing. Previously, Mark worked as an R&D Senior Cell Biologist at Unilever R&D, where they combined project management with laboratory skills to drive innovative research programs. Earlier in their career, Mark conducted postdoctoral research at the University of Manchester and served as an R&D Cell Biologist at Unilever R&D, establishing novel in vitro models and troubleshooting various technical challenges.
This person is not in the org chart
This person is not in any teams
This person is not in any offices